Clark Eliana - Insider Non-Derivative Transactions at Intellia Therapeutics, Inc. (NTLA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 1, 2024, Clark Eliana's relationship to Intellia Therapeutics, Inc. (NTLA) is Officer (EVP, Chief Technical Officer), and currently has 71,470 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NTLA insiders.
Data Source: SEC.
Clark Eliana - Insider Non-Derivative Transactions of NTLA Common Stock
Clark Eliana - Insider Non-Derivative Transactions at NTLA
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Jul 2, 2024 | Sell -- (Common Stock) | 405 | 22.93 | 71470 |
Mar 5, 2024 | Sell -- (Common Stock) | 605 | 32.99 | 71470 |
Mar 2, 2024 | Acquisition -- (Common Stock) | 31230 | 0 | 72075 |
Jan 4, 2024 | Sell -- (Common Stock) | 4301 | 29.46 | 40845 |
Jan 4, 2024 | Sell -- (Common Stock) | 307 | 30.12 | 45146 |
Jul 4, 2023 | Sell -- (Common Stock) | 360 | 40.51 | 45146 |
Jun 21, 2023 | Sell -- (Common Stock) | 5000 | 45 | 45146 |
Jun 21, 2023 | M -- (Common Stock) | 5000 | 12.27 | 50146 |
Mar 2, 2023 | Acquisition -- (Common Stock) | 24539 | 0 | 39012 |
Mar 2, 2023 | Acquisition -- (Common Stock) | 6134 | 0 | 45146 |
Jan 5, 2023 | Sell -- (Common Stock) | 1692 | 37.21 | 14473 |
Jan 4, 2023 | Sell -- (Common Stock) | 231 | 34.48 | 16165 |
Jul 2, 2022 | Sell -- (Common Stock) | 105 | 51.74 | 16165 |